A 55-year-old man presents with chest pain and ECG showing ST-segment depression and T-wave inversion in the lateral leads. Troponin is elevated. He is diagnosed with a non-ST-elevation myocardial infarction (NSTEMI). In addition to antiplatelet and anticoagulant therapy, which medication class has the strongest evidence for long-term mortality reduction and should be commenced early unless contraindicated?